The Price of Remission: This Cancer Drug Saves Lives -- but Costs a Fortune. I Wanted to Know Why. [View all]
https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma
The pain jolted me awake. It was barely dawn, a misty February morning in 2023. My side felt as if Id been stabbed.
I had been dealing with pain for weeks a bothersome ache that felt like a bad runners cramp. But now it was so intense I had to brace myself against the wall to stand up.
A few hours after arriving at the emergency room, I heard my name. A doctor asked me to follow him to a private area, where he told me a scan had uncovered something concerning.
There were lesions, areas of bone destruction, on top of both of my hip bones and on my sternum. These were hallmarks of multiple myeloma. Cancer, he said.
Multiple myeloma is a blood cancer that ravages bone, leaving distinctive holes in its wake. Subsequent scans showed innumerable lesions from my neck to my feet as well as two broken ribs and a compression fracture in my spine. There is no cure.
I walked out of the ER in search of fresh air. I sat on a metal bench and did what many patients do. I turned to Google. The first link was a medical review stating that the average lifespan of a newly diagnosed patient was three to five years. My stomach churned.
Cancer drug Revlimid is one of the bestselling pharmaceutical products of all time, with total sales of over 0 billion.
Itâs also extraordinarily expensive, costing nearly ,000 for each pill, even though that pill costs just 25 cents to make.
By @davidarmstrongx.bsky.social
— ProPublica (@propublica.org) 2025-11-28T23:00:11.498676284Z